Brand name : STABLON ® /
TIANEPTINE
INGREDIENTS:
Each tablet contains: Tianeptine (sodium salt) 12.5 mg
Excipients:
Mannitol, corn starch, magnesium stearate, ethyl cellulose, glycerol
oleate, polyvidone, sodium carboxymethyl cellulose, silica, talc, titanium
dioxide, bicarbonate of soda, wax, sucrose, polysorbate.
PHARMACEUTICAL CLASSIFICATION:
Anti-depressant
THERAPEUTICAL INDICATIONS:
* Neurotic or reactive states of depression
* Angiodepressive states with somatic complaints such as digestive problems
* Angiodepressive states observed in the alcoholic undergoing detoxification
CONTRAINDICATIONS:
This medicine should not be used: With MAO inhibitors (as a rule, there
should be an interval of 15 days between a MAOI and Tianeptine treatments)
By expectant or nursing mothers. By children of less than 15 years
of age. Should you have any doubt, consult your doctor.
ADVERSE EFFECTS:
As with any active pharmaceutical product, this medicine may cause
somewhat unpleasant side effects in certain patients. Although such
effects are rare, usually mild and temporary, they include: Gastralgia,
abdominal pain, dryness of the mouth, anorexia, nausea, vomiting, flatulence,
Insomnia, drowsiness, nightmares, asthenia, Tachycardia, extrasystole,
precordialgia, Dizziness, headaches, faintness, trembling, upsets,
Respiratory discomfort, tightness of the throat, Myalgia, lumbago,
Any of the abovementioned should be reported to your doctor or chemist
in addition to any adverse effects not mentioned in this leaflet.
INTERACTIONS:
Do not use this product with MAO indicators (see Contraindications)
To prevent accidental interactions between different medicines, inform
your doctor or chemist regularly if you should be taking any other
pharmaceutical product.
PRECAUTION:
* Any patient about to undergo general anaesthetic should inform
the anaesthetist and stop treatment 24 to 48 hours before the medical
intervention. Should an emergency operation prove to be necessary,
this may be carried out without stopping treatment previously but with
the correct operative supervision.
* As with other anti-depressants, when treatment is to be stopped, reduce the
dosage gradually over a period of 7 to 14 days.
* Inform your doctor if you are pregnant or breast-feeding your baby.
USE DURING PREGNANCY AND BREAST-FEEDING:
This medicine should not be used during pregnancy or breast-feeding.
EFFECTS ON THE PATIENT'S CAPACITY TO DRIVE OR USE MACHINERY:
Certain patients may experience drowsiness.
Keep in mind the risks involved with the drowsiness that this medicine
may cause.
DOSAGE AND DIRECTIONS FOR USE:
* The recommended dosage is 1 tablet taken by mouth, 3 times daily,
before breakfast, lunch and dinner.
* This dosage should be lowered for patients over 70 years of age and those
with renal problems.
Do not interrupt treatment without first consulting your doctor and
follow his instructions.
OVERDOSE:
In the event of massive swallowing of these tablets, go to your doctor
or the nearest hospital.
In any case, stop treatment. Emergency treatment involves the following:
* gastric lavage
* cardio-respiratory, metabolic and renal supervision and symptomatic treatment
of accompanying alterations and disorders.
STORAGE:
